- Record: found
- Abstract: found
- Article: found
Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment
review-article
Mi Zhang
a
,
1 ,
Wenhui Hu
a
,
1 ,
Chenhui Cai
b ,
Yu Wu
a
,
c ,
Jianmei Li
a ,
Shiwu Dong
a
,
d
,
∗
21 February 2022
Stimuli-responsive drug delivery system,
Inflammatory arthritis,
Cartilage degeneration,
Synovitis,
Subchondral bone destruction,
AIA, adjuvant-induced arthritis,
ACLT, anterior cruciate ligament transection,
ADAMTS, a disintegrin and metalloproteinase with thrombospondin motifs,
AMF, alternating magnetic field,
APCs, antigen-presenting cells,
BBR, berberine,
CAT, catalase,
CaP, calcium phosphate,
CD44, cluster of differentiation 44,
CEL, tripterine,
CEL-PRNPs, RGD-modified PLGA enzyme-responsive nanoparticles loaded with tripterine,
CIA, collagen-induced arthritis,
CTSK, cathepsin K,
DCF, diclofenac,
Dex/Oxi-α CDNPs, 4-phenylborate-cyclodextrin biomaterial loaded with dexamethasone,
DEX-P, dexamethasone sodium phosphate,
DMARDs, disease-modifying anti-rheumatic drugs,
DMM, destabilization of medial meniscus,
ECM, extracellular matrix,
ELP, elastin-like peptide,
ERK1/2, extracellular signal-regulated kinase 1/2,
FLSS, fibroblast synovial cells,
fMRI, focusing magnetic resonance imaging,
GPX, glutathione peroxidase,
GSH, glutathione,
HA, hyaluronic acid,
HIFU, high intensity focused ultrasound,
HM, hollow microsphere,
IBU, ibuprofen,
IGF-1, insulin-like growth factor-1,
IL, interleukin,
IL-1Ra, interleukin-1 receptor antagonist,
KAFAK, KAFAKLAARLYRKALARQLGVAA,
K/BxN, the T cell receptor transgene KRN and the MHC class II molecule,
KGN, kartogenin,
LDH, lactate dehydrogenase,
LPS, lipopolysaccharide,
MAPK, mitogen-activated protein kinase,
MFGCN, methotrexate-loaded folate-conjugated glycol chitosan nanoparticles,
MHC, major histocompatibility complex,
MMPs, matrix metalloproteinases,
MNPs, multifunctional nanoparticles,
MOF, metal-organic framework,
MP-HANPs, mineralized nanoparticles,
MPEG-PPF, methoxy polyethylene glycol-polypropylene fumarate,
MRI, magnetic resonance imaging,
MTX, methotrexate,
NADPH, nicotinamide adenine dinucleotide phosphate,
NFATc1, nuclear factor of activated T cell cytoplasmic 1,
NGPEGSS, nanoparticles with degradable disulfide crosslinks,
NIR, near-infrared,
NO, nitric oxide,
NP, nanoparticle,
NP-gel, nanoparticle-hydrogel hybrid system,
Nrf2, nuclear factor erythroid 2-related factor 2,
NSAIDs, non-steroidal anti-inflammatory drugs,
OA, osteoarthritis,
PCA, protocatechuic acid,
PDT, photodynamic therapy,
PEG-PLGA-Au, polyethylene-glycol polylactic-glycolic acid gold-containing nanoparticles,
PEVS, platelet-derived extracellular vesicles,
P-HA, polyethylene glycol hyaluronic acid,
PLCG1, phospholipase C gamma 1,
PLGA, polylactic-glycolic acid,
PON1, paraoxonase-1,
PTH, parathyroid hormone,
PTT, photothermal therapy,
Q, a tripeptide sequence QAW,
PAMAM, poly (Ninylisobutyramide),
PDEPT, pre-enzyme drug therapy,
PEOx-PPOy-PEOz, poly (ethylene oxide)-block-poly (Oxypropylene)-block-poly (ethylene oxide) ,
PICsomes, polyion complex vesicles,
PMEOMA, poly [2-(2-methoxyethoxy) ethylmethacrylate],
PNC, bisphosphonate-modified nanocellulose,
PNIPAM, poly (N-isopropyl acrylamide),
POxs, poly (2-oxazoline),
PPS, polyphenylene sulfide,
RA, rheumatoid arthritis,
RANKL, nuclear factor-kappa B ligand,
Redox, reduction-oxidation,
RFA, radiofrequency thermal ablation,
RGD, arginine-glycine-aspartic acid,
RMTQ, RGD-MMP-TAT-QAW peptide,
ROS, reactive oxygen species,
SBC, sodium bicarbonate,
SOD, superoxide dismutase,
SPION, superparamagnetic iron oxide nanoparticles,
T, cell-penetrating peptide,
TA, triamcinolone acetonide,
TAT, transcription-transactivating,
TATQ, TAT-QAW,
TG-18, triglycerol monostearate,
T cell, thymus cell,
TIMP, tissue inhibitor of metalloproteinase,
TNF, tumor necrosis factor,
TolDex, tolerogenic dendritic cell-derived exosomes,
TR1, type 1 regulatory,
US, ultrasound,
VEGF, vascular endothelial growth factor,
β-TCP, β-tricalcium phosphate
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Inflammatory arthritis is a major cause of disability in the elderly. This condition causes joint pain, loss of function, and deterioration of quality of life, mainly due to osteoarthritis (OA) and rheumatoid arthritis (RA). Currently, available treatment options for inflammatory arthritis include anti-inflammatory medications administered via oral, topical, or intra-articular routes, surgery, and physical rehabilitation. Novel alternative approaches to managing inflammatory arthritis, so far, remain the grand challenge owing to catastrophic financial burden and insignificant therapeutic benefit. In the view of non-targeted systemic cytotoxicity and limited bioavailability of drug therapies, a major concern is to establish stimuli-responsive drug delivery systems using nanomaterials with on-off switching potential for biomedical applications. This review summarizes the advanced applications of triggerable nanomaterials dependent on various internal stimuli (including reduction-oxidation (redox), pH, and enzymes) and external stimuli (including temperature, ultrasound (US), magnetic, photo, voltage, and mechanical friction). The review also explores the progress and challenges with the use of stimuli-responsive nanomaterials to manage inflammatory arthritis based on pathological changes, including cartilage degeneration, synovitis, and subchondral bone destruction. Exposure to appropriate stimuli induced by such histopathological alterations can trigger the release of therapeutic medications, imperative in the joint-targeted treatment of inflammatory arthritis.
Graphical abstract
Related collections
Most cited references156
- Record: found
- Abstract: found
- Article: not found
Stimuli-responsive nanocarriers for drug delivery.
Simona Mura, Julien Nicolas, Patrick Couvreur … (2014)
- Record: found
- Abstract: found
- Article: not found
The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis.
Jérémie Sellam, Francis Berenbaum (2010)
Author and article information
stimuli-responsive drug delivery system,inflammatory arthritis,cartilage degeneration,synovitis,subchondral bone destruction,aia, adjuvant-induced arthritis,aclt, anterior cruciate ligament transection,adamts, a disintegrin and metalloproteinase with thrombospondin motifs,amf, alternating magnetic field,apcs, antigen-presenting cells,bbr, berberine,cat, catalase,cap, calcium phosphate,cd44, cluster of differentiation 44,cel, tripterine,cel-prnps, rgd-modified plga enzyme-responsive nanoparticles loaded with tripterine,cia, collagen-induced arthritis,ctsk, cathepsin k,dcf, diclofenac,dex/oxi-α cdnps, 4-phenylborate-cyclodextrin biomaterial loaded with dexamethasone,dex-p, dexamethasone sodium phosphate,dmards, disease-modifying anti-rheumatic drugs,dmm, destabilization of medial meniscus,ecm, extracellular matrix,elp, elastin-like peptide,erk1/2, extracellular signal-regulated kinase 1/2,flss, fibroblast synovial cells,fmri, focusing magnetic resonance imaging,gpx, glutathione peroxidase,gsh, glutathione,ha, hyaluronic acid,hifu, high intensity focused ultrasound,hm, hollow microsphere,ibu, ibuprofen,igf-1, insulin-like growth factor-1,il, interleukin,il-1ra, interleukin-1 receptor antagonist,kafak, kafaklaarlyrkalarqlgvaa,k/bxn, the t cell receptor transgene krn and the mhc class ii molecule,kgn, kartogenin,ldh, lactate dehydrogenase,lps, lipopolysaccharide,mapk, mitogen-activated protein kinase,mfgcn, methotrexate-loaded folate-conjugated glycol chitosan nanoparticles,mhc, major histocompatibility complex,mmps, matrix metalloproteinases,mnps, multifunctional nanoparticles,mof, metal-organic framework,mp-hanps, mineralized nanoparticles,mpeg-ppf, methoxy polyethylene glycol-polypropylene fumarate,mri, magnetic resonance imaging,mtx, methotrexate,nadph, nicotinamide adenine dinucleotide phosphate,nfatc1, nuclear factor of activated t cell cytoplasmic 1,ngpegss, nanoparticles with degradable disulfide crosslinks,nir, near-infrared,no, nitric oxide,np, nanoparticle,np-gel, nanoparticle-hydrogel hybrid system,nrf2, nuclear factor erythroid 2-related factor 2,nsaids, non-steroidal anti-inflammatory drugs,oa, osteoarthritis,pca, protocatechuic acid,pdt, photodynamic therapy,peg-plga-au, polyethylene-glycol polylactic-glycolic acid gold-containing nanoparticles,pevs, platelet-derived extracellular vesicles,p-ha, polyethylene glycol hyaluronic acid,plcg1, phospholipase c gamma 1,plga, polylactic-glycolic acid,pon1, paraoxonase-1,pth, parathyroid hormone,ptt, photothermal therapy,q, a tripeptide sequence qaw,pamam, poly (ninylisobutyramide),pdept, pre-enzyme drug therapy,peox-ppoy-peoz, poly (ethylene oxide)-block-poly (oxypropylene)-block-poly (ethylene oxide),picsomes, polyion complex vesicles,pmeoma, poly [2-(2-methoxyethoxy) ethylmethacrylate],pnc, bisphosphonate-modified nanocellulose,pnipam, poly (n-isopropyl acrylamide),poxs, poly (2-oxazoline),pps, polyphenylene sulfide,ra, rheumatoid arthritis,rankl, nuclear factor-kappa b ligand,redox, reduction-oxidation,rfa, radiofrequency thermal ablation,rgd, arginine-glycine-aspartic acid,rmtq, rgd-mmp-tat-qaw peptide,ros, reactive oxygen species,sbc, sodium bicarbonate,sod, superoxide dismutase,spion, superparamagnetic iron oxide nanoparticles,t, cell-penetrating peptide,ta, triamcinolone acetonide,tat, transcription-transactivating,tatq, tat-qaw,tg-18, triglycerol monostearate,t cell, thymus cell,timp, tissue inhibitor of metalloproteinase,tnf, tumor necrosis factor,toldex, tolerogenic dendritic cell-derived exosomes,tr1, type 1 regulatory,us, ultrasound,vegf, vascular endothelial growth factor,β-tcp, β-tricalcium phosphate
stimuli-responsive drug delivery system, inflammatory arthritis, cartilage degeneration, synovitis, subchondral bone destruction, aia, adjuvant-induced arthritis, aclt, anterior cruciate ligament transection, adamts, a disintegrin and metalloproteinase with thrombospondin motifs, amf, alternating magnetic field, apcs, antigen-presenting cells, bbr, berberine, cat, catalase, cap, calcium phosphate, cd44, cluster of differentiation 44, cel, tripterine, cel-prnps, rgd-modified plga enzyme-responsive nanoparticles loaded with tripterine, cia, collagen-induced arthritis, ctsk, cathepsin k, dcf, diclofenac, dex/oxi-α cdnps, 4-phenylborate-cyclodextrin biomaterial loaded with dexamethasone, dex-p, dexamethasone sodium phosphate, dmards, disease-modifying anti-rheumatic drugs, dmm, destabilization of medial meniscus, ecm, extracellular matrix, elp, elastin-like peptide, erk1/2, extracellular signal-regulated kinase 1/2, flss, fibroblast synovial cells, fmri, focusing magnetic resonance imaging, gpx, glutathione peroxidase, gsh, glutathione, ha, hyaluronic acid, hifu, high intensity focused ultrasound, hm, hollow microsphere, ibu, ibuprofen, igf-1, insulin-like growth factor-1, il, interleukin, il-1ra, interleukin-1 receptor antagonist, kafak, kafaklaarlyrkalarqlgvaa, k/bxn, the t cell receptor transgene krn and the mhc class ii molecule, kgn, kartogenin, ldh, lactate dehydrogenase, lps, lipopolysaccharide, mapk, mitogen-activated protein kinase, mfgcn, methotrexate-loaded folate-conjugated glycol chitosan nanoparticles, mhc, major histocompatibility complex, mmps, matrix metalloproteinases, mnps, multifunctional nanoparticles, mof, metal-organic framework, mp-hanps, mineralized nanoparticles, mpeg-ppf, methoxy polyethylene glycol-polypropylene fumarate, mri, magnetic resonance imaging, mtx, methotrexate, nadph, nicotinamide adenine dinucleotide phosphate, nfatc1, nuclear factor of activated t cell cytoplasmic 1, ngpegss, nanoparticles with degradable disulfide crosslinks, nir, near-infrared, no, nitric oxide, np, nanoparticle, np-gel, nanoparticle-hydrogel hybrid system, nrf2, nuclear factor erythroid 2-related factor 2, nsaids, non-steroidal anti-inflammatory drugs, oa, osteoarthritis, pca, protocatechuic acid, pdt, photodynamic therapy, peg-plga-au, polyethylene-glycol polylactic-glycolic acid gold-containing nanoparticles, pevs, platelet-derived extracellular vesicles, p-ha, polyethylene glycol hyaluronic acid, plcg1, phospholipase c gamma 1, plga, polylactic-glycolic acid, pon1, paraoxonase-1, pth, parathyroid hormone, ptt, photothermal therapy, q, a tripeptide sequence qaw, pamam, poly (ninylisobutyramide), pdept, pre-enzyme drug therapy, peox-ppoy-peoz, poly (ethylene oxide)-block-poly (oxypropylene)-block-poly (ethylene oxide), picsomes, polyion complex vesicles, pmeoma, poly [2-(2-methoxyethoxy) ethylmethacrylate], pnc, bisphosphonate-modified nanocellulose, pnipam, poly (n-isopropyl acrylamide), poxs, poly (2-oxazoline), pps, polyphenylene sulfide, ra, rheumatoid arthritis, rankl, nuclear factor-kappa b ligand, redox, reduction-oxidation, rfa, radiofrequency thermal ablation, rgd, arginine-glycine-aspartic acid, rmtq, rgd-mmp-tat-qaw peptide, ros, reactive oxygen species, sbc, sodium bicarbonate, sod, superoxide dismutase, spion, superparamagnetic iron oxide nanoparticles, t, cell-penetrating peptide, ta, triamcinolone acetonide, tat, transcription-transactivating, tatq, tat-qaw, tg-18, triglycerol monostearate, t cell, thymus cell, timp, tissue inhibitor of metalloproteinase, tnf, tumor necrosis factor, toldex, tolerogenic dendritic cell-derived exosomes, tr1, type 1 regulatory, us, ultrasound, vegf, vascular endothelial growth factor, β-tcp, β-tricalcium phosphate